Adverse reactions to infusion fluids

Perioperative Fluid Therapy

Volumn , Issue , 2016, Pages 459-476

  Haljamäe, Hengo ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885500531     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (103)

1. Järvelä K, Kääbi T, Kauppinen P, Kaukinen S. Effects of hypertonic 75 mg/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia. Acta Anaesthesiol Scand 2001; 45:776-781.
2. Tølløfsrud S, Bjerkelund CE, Kongsgaard U, Hall C, Noddeland H. Cold and warm infusion of Ringer's acetate in healthy volunteers: the effects on haemodynamic parameters, transcapillary fluid balance, diuresis and atrial peptides. Acta Anaesthesiol Scand 1993; 37:768-773.
3. Tølløfsrud S, Tønnessen T, Skraastad O, Noddeland H. Hypertonic saline and dextran in normovolaemic and hypovolaemic healthy volunteers increases interstitial and intravascular fluid volumes. Acta Anaesthesiol Scand 1998; 42:145-153.
4. Peskind ER, Jensen CF, Pascualy M, et al. Sodium lactate and hypertonic sodium chloride induce equivalent panic incidence, panic symptoms, and hypernatremia in panic disorder. Biol Psychiatr 1998; 44:1007-1016.
5. Haljamäe H, Dahlqvist M, Walentin F. Artificial colloids in clinical practice: pros and cons. Bailliè re's Clin Anaesthesiol 1997; 11:49-79.
6. Tønnessen T, Tølløfsrud S, Kongsgaard UE, Noddeland H. Colloid osmotic pressure of plasma replacement fluids. Acta Anaesthesiol Scand 1993; 37:424-426.
7. Järvelä K, Honkonen SE, Järvelä T, Kääbi T, Kaukinen S. The comparison of hypertonic saline (7.5%) and normal saline (0.9%) for initial fluid administration before spinal anesthesia. Anesth Analg 2000; 91:1461-1465.
8. Haglind E, Haljamäe H. Failure of hypertonic saline to resuscitate intestinal ischemia shock in the rat. Acta Anaesthesiol Scand 1992; 36:410-418.
9. Waagstein L, Haljamäe H, Ricksten S-E, Sahlman L. Effects of hypertonic saline on myocardial function and metabolism in non-ischemic and ischemic isolated working rat heart. Crit Care Med 1995; 23:1890-1897.
10. Kien ND, Kramer GC, White DA. Acute hypotension caused by rapid hypertonic saline infusion in anesthetized dogs. Anesth Analg 1991; 73:597-602.
11. Haljamäe H. Crystalloids versus colloids: the controversy. NATA Textbook. Paris: R & J Éditions Médicale, 1999:27-36.
12. Larsson M, Ware J. Effects of isotonic fluid load on plasma water and extracellular fluid volumes in the rat. Eur Surg Res 1983; 15:262-267.
13. Velanovich V. Crystalloid versus colloid fluid resuscitation: a meta-analysis of mortality. Surgery 1989; 105:65-71.
14. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 1998; 316:961-964.
15. Choi PT, Yip G, Quinonez LG, Cook DJ. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999; 27:200-210.
16. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systemic review of randomised controlled trials. BMJ 1998; 317:235-240.
17. Wisner DH, Sturm JA. Controversies in the fluid management of post-traumatic lung disease. Injury 1986; 17:295-300.
18. Hauser CJ, Shoemaker WC, Turpin I, Goldberg SJ. Oxygen transport responses to colloids and crystalloids in critically ill surgical patients. Surg Gynecol Obstet 1980; 150:811-816.
19. Lucas CE, Ledgerwood AM, Shier MR, Bradley VE. The renal factor in the post-traumatic "fluid overload" syndrome. J Trauma 1977; 17:667-676.
20. Arieff AI. Fatal postoperative pulmonary edema: pathogenesis and literature review. Chest 1999; 115:1371-1377.
21. Møller AM, Pedersen T, Svendsen P-E, Engquist A. Perioperative risk factors in elective pneumonectomy: the impact of excess fluid balance. Eur J Anaesthesiol 2002; 19:57-62.
22. Bäck JC, Barker BC, Clinton AG, Wilson MB, Lewis FR. Post-traumatic changes in, and effect of colloid osmotic pressure on the distribution of body water. Ann Surg 1990; 9:3-6.
23. Lowell JA, Schifferdecker C, Driscoll DF, Benotti PN, Bistrian BR. Postoperative fluid overload: not a benign problem. Crit Care Med 1990; 18:728-733.
24. Prien T, Backhaus N, Pelser F, Pircher W, Bünte H, Lawin P. Effects of intraoperative fluid administration and colloid osmotic pressure on the formation of intestinal edema during gastrointestinal surgery. J Clin Anesth 1990; 2:317-323.
25. Lang K, Boldt J, Suttner S, Haisch G. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Analg 2001; 93:405-409.
26. Mythen MG, Webb AR. Intra-operative gut mucosal hypoperfusion is associated with increased post-operative complications and cost. Intensive Care Med 1994; 20:99-104.
27. Rohrer MJ, Natale AM. Effect of hypothermia on the coagulation cascade. Crit Care Med 1992; 20:1402-1405.
28. Ferrara A, MacArthur JD, Wright HK, Modlin IM, McMillen MA. Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. Am J Surg 1990; 160:515-518.
29. McFarlane C, Lee A. A comparison of Plasmalyte 148 and 0.9% saline for intraoperative fluid replacement. Anaesthesia 1994; 49:779-781.
30. Lowery BD, Cloutier CT, Carey LC. Electrolyte solutions in resuscitation in human hemorrhagic shock. Surg Gynecol Obstet 1971; 133:272-284.
31. Waters JH, Miller LR, Clack S, Kim JV. Cause of metabolic acidosis in prolonged surgery. Crit Care Med 1999; 27:2142-2146.
32. Stephens RC, Mythen MG. Saline based fluids can cause a significant acidosis that may be clinically relevant. Crit Care Med 2000; 28:3375-3377.
33. Skellett S, Mayer A, Durward A, Tibby SM, Murdoch IA. Chasing the base deficit: hyperchloraemic acidosis following 0.9% saline fluid resuscitation. Arch Dis Child 2000; 83:514-516.
34. Scheingraber S, Rehm M, Sehmisch C, Finsterer U. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecological surgery. Anesthesiology 1999; 90:1265-1270.
35. Wilkes NJ, Woolf R, Mutch M, et al. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 2001; 93:811-816.
36. Haljamäe H. Use of fluids in trauma. Int J Intens Care 1999; 6:20-30.
37. Moon PF, Kramer GC. Hypertonic saline-dextran resuscitation from hemorrhagic shock induces transient mixed acidosis. Crit Care Med 1995; 23:323-331.
38. Ruttmann TG, James MF, Viljoen JF. Haemodilution induces a hypercoagulable state. Br J Anaesth 1996; 76:412-414.
39. Ruttmann TG, James MF, Aronson I. In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation. Br J Anaesth 1998; 80:612-616.
40. Ruttmann TG, Jamest MF, Lombard EH. Haemodilution-induced enhancement of coagulation is attenuated in vitro by restoring antithrombin III to pre-dilution concentrations. Anaesth Intensive Care 2001; 29:489-493.
41. Niemi TT, Kuitunen AH. Hydroxyethyl starch impairs in vitro coagulation. Acta Anaesthesiol Scand 1998; 42:1104-1109.
42. Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med 1999; 25:258-268.
43. Warren BB, Durieux ME. Hydroxyethyl starch: safe or not?. Anesth Analg 1997; 84:206-212.
44. de Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 2001; 29:1261-1267.
45. Franz A, Braunlich P, Gamsjager T, Felfernig M, Gustorff B, Kozek-Langenecker SA. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 2001; 92:1402-1407.
46. Macintyre E, Mackie IJ, Ho D, Tinker J, Bullen C, Machin SJ. The haemostatic effects of hydroxyethyl starch (HES) used as a volume expander. Intensive Care Med 1985; 11:300-303.
47. Huraux C, Ankri AA, Eyraud D, et al. Hemostatic changes in patients receiving hydroxyethyl starch: the influence of ABO blood group. Anesth Analg 2001; 92:1396-1401.
48. Entholzner EK, Mielke LL, Calatzis AN, Feyh J, Hipp R, Hargasser SR. Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight. Acta Anaesthesiol Scand 2000; 44:1116-1121.
49. Jamnicki M, Bombeli T, Seifert B, et al. Low- and medium-molecular-weight hydroxyethyl starches:comparison of their effect on blood coagulation. Anesthesiology 2000; 93:1231-1237.
50. Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat P. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 2001; 92:855-862.
51. Arfors K-E, Buckley PB. Pharmacological characteristics of artificial colloids. Baillière's Clin Anaesthesiol 1997; 11:15-47.
52. Bergqvist D, Bergentz S-E. The role of dextran in severe ischemic extremity disease and arterial reconstructive surgery. VASA 1983; 12:213-218.
53. Matthiasson SE, Lindblad B, Matzsch T, Molin J, Qvarford P, Bergqvist D. Study of the interaction of dextran and enoxaparin on haemostasis in humans. Thromb Haemost 1994; 72:722-727.
54. Lethagen S, Rugarn P, Bergqvist D. Blood loss and safety with desmopressin or placebo during aorto-iliac graft surgery. Eur J Vasc Surg 1991; 5:173-178.
55. Schätt U, Sollen C, Axelsson K, Rugarn P, Allvin I. Desmopressin acetate does not reduce blood loss during total hip replacement in patients receiving dextran. Acta Anaesthesiol Scand 1995; 39:592-598.
56. Frost-Arner L, Bergqvist D. Effects of heparin, desmopressin, and isovolemic hemodilution with dextran on thrombus formation in synthetic vessel grafts inserted into the vena cava of the rabbit. J Vasc Surg 1998; 28:506-513.
57. Karoutsos S, Nathan N, Lahrimi A, Grouille D, Feiss P, Cox DJ. Thrombelastogram reveals hypercoagulability after administration of gelatin solution. Br J Anaesth 1999; 82:175-177.
58. Petroianu GA, Liu J, Maleck WH, Mattinger C, Bergler WF. The effect of in vitro hemodilution with gelatin, dextran, hydroxyethyl starch, or Ringer's solution on Thrombelastograph. Anesth Analg 2000; 90:795-800.
59. de Jonge E, Levi M, Berends F, van der Ende AE, ten Cate JW, Stoutenbeek CP. Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects. Thromb Haemost 1998; 79:286-290.
60. Evans PA, Glenn JR, Heptinstall S, Madira W. Effects of gelatin-based resuscitation fluids on platelet aggregation. Br J Anaesth 1998; 81:198-202.
61. Hüttner I, Boldt J, Haisch G, Suttner S, Kumle B, Schulz H. Influence of different colloids on molecular markers of haemostasis and platelet function in patients undergoing major abdominal surgery. Br J Anaesth 2000; 85:417-423.
62. Beyer R, Harmening U, Rittmeyer O, et al. Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery. Br J Anaesth 1997; 78:44-50.
63. Lorenz W, Duda D, Dick W, et al., and the Trial Group/Mainz/Marburg. Incidence and clinical importance of perioperative histamine release: randomised study of volume loading and antihistamines after induction of anaesthesia. Lancet 1994; 343:933-940.
64. Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes:incidence, risk factors, mechanisms. A French multicentre prospective study. Ann Fr Anesth Reanim 1994; 13:301-310.
65. Ljungsträm K-G. Safety of dextran in relation to other colloids-ten years experience with hapten inhibition. Infusionsther Transfusionsmed 1993; 20:206-210.
66. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; 1:466-469.
67. Hedin H, Richter W. Pathomechanisms of dextran-induced anaphylactoid/anaphylactic reactions in man. Int Arch Allergy Appl Immmun 1982; 68:122-126.
68. Porter SS, Goldberg RJ. Intraoperative allergic reactions to hydroxyethyl starch: a report of two cases. Can Anaesth Soc J 1986; 33:394-398.
69. Kraft D, Sirtl C, Laubenthal H, et al. No evidence for the existence of preformed antibodies against hydroxyethyl starch in man. Eur Surg Res 1992; 24:138-142.
70. Kreimeier U, Christ F, Kraft D, et al. Anaphylaxis due to hydroxyethyl-starch-reactive antibodies. Lancet 1995; 346:49-50.
71. Dieterich HJ, Kraft D, Sirtl C, et al. Hydroxyethyl starch antibodies in humans: incidence and clinical relevance. Anesth Analg 1998; 86:1123-1126.
72. Treib J, Haass A, Pindur G, Grauer MT, Wenzel E, Schimrigk K. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation. Transfusion 1996; 36:450-455.
73. Ljungsträm K-G, Renck H, Hedin H, Richter W, Wiholm B-E. Hapten inhibition and dextran anaphylaxis. Anaesthesia 1988; 43:729-732.
74. Ljungsträm K-G. Colloid safety: fact and fiction. Baillière's Clin Anaesthesiol 1997; 11:163-177.
75. Lorenz W, Doenicke A, Messmer K, et al. Histamine release in human subjects by modified gelatin (Haemaccel) and dextran: an explanation for anaphylactoid reactions observed under clinical conditions? Br J Anaesth 1976; 48:151-165.
76. Ford SA, Kam PC, Baldo BA, Fisher MM. Anaphylactic or anaphylactoid reactions in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2001; 15:684-688.
77. Vervloet D, Senft M, Dugue P, Arnaud A, Charpin J. Anaphylactic reactions to modified fluid gelatins. J Allergy Clin Immunol 1983; 71:535-540.
78. Sakaguchi M, Miyazawa H, Inouye S. Sensitization to gelatin in children with systemic nonimmediate- type reactions to varicella vaccines. Ann Allergy Asthma Immunol 2000; 84:341-344.
79. Bunn F, Alderson P, Hawkins V. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 2001; 2:CD001319.
80. Sirtl C, Laubenthal H, Zumtobel V, Kraft D, Jurecka W. Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related. Br J Anaesth 1999; 82:510-515.
81. Brodin B, Hesselvik F, von Schenck H. Decrease of plasma fibronectin concentration following infusion of a gelatin-based plasma substitute in man. Scand J Clin Lab Invest 1984; 44:529-533.
82. Spittal MJ, Findlay GP. The seven year itch. Anaesthesia 1995; 50:913-914.
83. Parker NE, Porter JB,Williams HJM, Leftley N. Pruritus after administration of hetastarch. Br Med J 1982; 284:385-386.
84. Kimme P, Jannsen B, Ledin T, Gupta A, Vegfors M. High incidence of pruritus after large doses of hydroxyethyl starch (HES) infusion. Acta Anaesthesiol Scand 2001; 45:686-689.
85. Murphy M, Carmichael AJ, Lawler PG, White M, Cos NH. The incidence of hydroxyethyl starchassociated pruritus. Br J Dermatol 2001; 144:973-976.
86. Bothner U, Georgieff M, Vogt NH. Assessment of the safety and tolerance of 6% hydroxyethyl starch (200/0.5) solution: a randomized controlled epidemiology study. Anesth Analg 1998; 86:850-855.
87. Jurecka W, Szépfalusi Z, Parth E, et al. Hydroxyethylstarch deposits in human skin-a model for pruritus? Arch Dermatol Res 1993; 285:13-19.
88. Metze D, Reimann S, Szépfalusi Z, Bohle B, Draft D, Luger TA. Persistent pruritus after hydroxyethyl starch infusion therapy: a result of long-term storage in cutaneous nerves. Br J Dermatol 1997; 136:553-559.
89. Reimann S, Szépfalusi Z, Kraft D, Luger T, Metze D. Hydroxyethylstärke-Speicherung in der Haut under besonderer Berücksichtigung des Hydroxyethylstärke-assoziierten Juckreizes. Dtsch Med Wochenschr 2000; 125:280-285.
90. Moran M, Kapsner C. Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 1987; 317:150-153.
91. Haskell LP, Tannenberg AM. Elevated urinary specific gravity in acute oliguric renal failure due to HES. NY State J Med 1988; 88:387-388.
92. Hussain SF, Drew PJ. Acute renal failure after infusion of gelatins. BMJ 1989; 299:1137-1138.
93. Cittanova ML, Lebanc I, Legendre C, Mouquet C, Riou C, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renalfunction in kidney-transplant recipients. Lancet 1996; 348:1620-1622.
94. Deman A, Peeters P, Sennesael J. Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: a retrospective, multicentre analysis. Nephrol Dial Transplant 1999; 14:1517-1520.
95. Schortgen F, Lacherade JC, Bruneel F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001; 357:911-916.
96. Dehne MG, Muhling J, Sablotzki A, Dehne K, Sucke N, Hempelmann G. Hydroxyethyl starch (HES) does not directly affect renal function in patients with no prior renal impairment. J Clin Anesth 2001; 13:103-111.
97. Ragaller MJ, Theilen H, Koch T. Volume replacement in critically ill patients with acute renal failure. J Am Soc Nephrol 2001; 12(suppl 17):S33-S39.
98. Peron S, Mouthon L, Guettier C, Brechignac S, Cohen P, Guillevin L. Hydroxyethyl starch-induced renal insufficiency after plasma exchange in a patient with polymyositis and liver cirrhosis. Clin Nephrol 2001; 55:408-411.
99. Christidis C, Mal F, Ramos J, et al. Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions. J Hepatol 2001; 35:726-732.
100. Roche P, Dodelin RA, Bloom WL. Effect of dextran on blood typing and crossmatching. Blood 1952; 7:373-375.
101. Marston NA. Crossmatching of blood in the presence of dextrans. Lancet 1954; ii:688.
102. Bartholomew JR, Bell WR, Kicker T, Williams GM. A prospective study of the effect of dextran administration on compatibility testing. Transfusion 1986; 26:431-433.
103. Moore GL, Summary JJ, Dubick MA, et al. Effects of hypertonic saline (7.5%)/dextran 70 on human red cell typing, lysis, and metabolism in vitro. Vox Sang 1990; 59:227-231.